Celularity Inc. (CELU)

NASDAQ: CELU · IEX Real-Time Price · USD
5.60
-0.08 (-1.41%)
At close: Mar 18, 2024, 4:00 PM
5.59
-0.01 (-0.18%)
After-hours: Mar 18, 2024, 4:40 PM EDT

Total Valuation

Celularity has a market cap or net worth of $121.98 million. The enterprise value is $165.89 million.

Market Cap 121.98M
Enterprise Value 165.89M

Important Dates

The next estimated earnings date is Monday, April 1, 2024, after market close.

Earnings Date Apr 1, 2024
Ex-Dividend Date n/a

Share Statistics

Celularity has 21.78 million shares outstanding. The number of shares has increased by 25.09% in one year.

Shares Outstanding 21.78M
Shares Change (YoY) +25.09%
Shares Change (QoQ) +6.66%
Owned by Insiders (%) 51.13%
Owned by Institutions (%) 14.67%
Float 9.43M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 8.25
Forward PS n/a
PB Ratio 4.03
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 11.22
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.20, with a Debt / Equity ratio of 2.02.

Current Ratio 0.20
Quick Ratio 0.25
Debt / Equity 2.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -76.12

Financial Efficiency

Return on equity (ROE) is -144.20% and return on invested capital (ROIC) is -378.09%.

Return on Equity (ROE) -144.20%
Return on Assets (ROA) -62.20%
Return on Capital (ROIC) -378.09%
Revenue Per Employee $65,724
Profits Per Employee -$806,258
Employee Count 225
Asset Turnover 0.05
Inventory Turnover 0.63

Taxes

In the past 12 months, Celularity has paid $13,000 in taxes.

Income Tax 13,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -4.44% in the last 52 weeks. The beta is 0.24, so Celularity's price volatility has been lower than the market average.

Beta (1Y) 0.24
52-Week Price Change -4.44%
50-Day Moving Average 4.02
200-Day Moving Average 3.58
Relative Strength Index (RSI) 58.93
Average Volume (30 Days) 287,403

Short Selling Information

The latest short interest is 466,640, so 2.14% of the outstanding shares have been sold short.

Short Interest 466,640
Short Previous Month 3.75M
Short % of Shares Out 2.14%
Short % of Float 4.95%
Short Ratio (days to cover) 3.86

Income Statement

In the last 12 months, Celularity had revenue of $14.79 million and -$181.41 million in losses. Loss per share was -$10.20.

Revenue 14.79M
Gross Profit -3.70M
Operating Income -345.29M
Pretax Income -181.40M
Net Income -181.41M
EBITDA -169.66M
EBIT -179.04M
Loss Per Share -$10.20
Full Income Statement

Balance Sheet

The company has $17.17 million in cash and $61.08 million in debt, giving a net cash position of -$43.91 million or -$2.02 per share.

Cash & Cash Equivalents 17.17M
Total Debt 61.08M
Net Cash -43.91M
Net Cash Per Share -$2.02
Equity / Book Value 30.25M
Book Value Per Share 1.39
Working Capital -68.13M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$63.93 million and capital expenditures -$1.25 million, giving a free cash flow of -$65.18 million.

Operating Cash Flow -63.93M
Capital Expenditures -1.25M
Free Cash Flow -65.18M
FCF Per Share -$3.46
Full Cash Flow Statement

Margins

Gross margin is -25.05%, with operating and profit margins of -2,334.95% and -1,226.72%.

Gross Margin -25.05%
Operating Margin -2,334.95%
Pretax Margin -1,226.64%
Profit Margin -1,226.72%
EBITDA Margin -1,147.25%
EBIT Margin -1,210.73%
FCF Margin -440.74%

Dividends & Yields

Celularity does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -25.09%
Shareholder Yield -25.09%
Earnings Yield -148.71%
FCF Yield -53.43%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on February 29, 2024. It was a reverse split with a ratio of 1:10.

Last Split Date Feb 29, 2024
Split Type Reverse
Split Ratio 1:10

Scores

Celularity has an Altman Z-Score of -11.19 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -11.19
Piotroski F-Score 3